SC
SUPN icon

SummitTX Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

SummitTX Capital’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
27,151
+18,106
+200% +$870K 0.03% 415
2026
Q1 		$468K Sell
9,045
-2,625
-22% -$134K 0.01% 576
2025
Q4 		$580K Buy
11,670
+303
+3% +$14.7K 0.02% 512
2025
Q3 		$543K Sell
11,367
-17,299
-60% -$697K 0.02% 512
2025
Q2 		$904K Sell
28,666
-6,824
-19% -$219K 0.04% 393
2025
Q1 		$1.16M Buy
+35,490
New +$1.26M 0.05% 371

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

SummitTX Capital's SUPN Position: Q2 2026 in Review

SummitTX Capital increased its Supernus Pharmaceuticals (SUPN) stake by 200% in Q2 2026, buying an estimated $870K and bringing the position to 27,151 shares worth $1.26M. The position accounts for 0.03% of the portfolio, ranked #415.

SummitTX Capital first reported a position in SUPN in Q1 2025 and has held it in 6 quarters since. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • SummitTX Capital held 27,151 shares of Supernus Pharmaceuticals worth $1.26M as of Q2 2026.
  • SummitTX Capital bought 18,106 Supernus Pharmaceuticals shares in Q2 2026, an estimated $870K.
  • Supernus Pharmaceuticals made up 0.03% of SummitTX Capital's portfolio in Q2 2026, its #415 holding.
  • SummitTX Capital first reported a position in Supernus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.